Latest Content

FDA Approves Brukinsa Tablet For Various Blood Cancers

June 12th 2025, 3:00pm

By Spencer Feldman

Article

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.

A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment

June 12th 2025, 1:00pm

By Dr. Michael Serzan

Video

Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

Being a Cancer Survivor is a Gift I Never Take for Granted

June 11th 2025, 9:00pm

By Kelly Irvin

Article

Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.

What Patients With Genitourinary Cancers Should Know After ASCO 2025

June 11th 2025, 8:00pm

By Dr. Joshua K. Sabari

Video

Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology

FDA Approves Ibtrozi for ROS1+ Advanced Non-Small Cell Lung Cancer

June 11th 2025, 5:40pm

By Spencer Feldman

Article

The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

Connected by Shared Experiences and What Cancer Can’t Take Away

June 11th 2025, 5:00pm

By Diana M. Martin

Article

Two people connect by sharing their experiences about taking care of their spouses who died from cancer, and the realization that sparked something more.

Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

June 11th 2025, 4:30pm

By Ryan Scott

Article

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

June 11th 2025, 3:00pm

By Spencer Feldman

Article

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.

How to Prepare for Self-Advocacy After a Cancer Diagnosis

June 11th 2025, 1:00pm

By Michelle Kirschner

Video

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

June 10th 2025, 9:00pm

By Jeanine Pronio

Article

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.

Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer

June 10th 2025, 8:00pm

By Dr. Sara M. Tolaney

Video

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

The LAURA Trial May Lead to a New Era of Care in Lung Cancer

June 10th 2025, 7:00pm

By Ryan Scott

Article

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell lung cancer.

A Letter to My 2009 Self, Newly Diagnosed With Breast Cancer

June 10th 2025, 5:00pm

By Brenda Denzler

Article

I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

June 10th 2025, 4:00pm

By Kristie L. Kahl

Article

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

June 10th 2025, 3:18pm

By Spencer Feldman

Article

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.